Results 11 to 20 of about 133 (82)
The path of least resistance: A case of cervical stenosis and uterocutaneous fistula [PDF]
Case Reports in Women's Health, 2015 Uterocutaneous fistula is exceedingly rare, and uniformly follows some type of operative procedure. In this case, a young woman underwent a cesarean delivery at an outlying clinic in rural Nigeria, following which she developed amenorrhea and cyclic ...
Steven Neil Shephard +1 more
doaj +4 more sources
Uterocutaneous fistula after cesarean section; Case report [PDF]
International Journal of Surgery Case Reports, 2021 Abstract Introduction and importance Fistula is an abnormal tract communicating two epithelial surfaces, uterocutaneous fistula is an extremely rare. The classical presentation is cyclical bleeding from an abnormal opening in the scar of previous cesarean section.
Dildar Haji Musa, Ayad Ahmad Mohammed
exaly +4 more sources
Uterocutaneous Fistula Following Cesarean Section: Successful Management of a Case [PDF]
Iranian Journal of Medical Sciences, 2016 A uterocutaneous fistula is a rare clinical presentation that occurs following Cesarean section and other pelvic operations. There are only a few reports discussing the treatments.
Ghodratollah Maddah +3 more
doaj +3 more sources
Laparoscopic Management of Post-Cesarean Section Uterocutaneous Fistula [PDF]
Journal of Obstetrics and Gynecology of India, 2019 A uterocutaneous fistula is a rare clinical presentation that occurs following cesarean section or any other pelvic surgery. We describe a case of uterocutaneous fistula with successful surgical management. A 25-year woman was referred to our hospital with complaints of cyclical bleeding from lower segment cesarean section scar (LSCS scar).
Pradnya Changede, Changede Pradnya
exaly +5 more sources
Uterocutaneous FistulaA Case Series [PDF]
Journal of Clinical and Diagnostic Research, 2021 Uterocutaneous Fistula (UCF) is an uncommon condition, which usually occurs as a postoperative complication. Authors, hereby presented three cases of UCF.
Nishi Choudhary +2 more
doaj +2 more sources
Total laparoscopic management of uterocutaneous fistulas: A case report and review of literature
Current Medicine Research and Practice, 2022 Uterocutaneous fistulae are rare fistulas of the female genitourinary tract. It mostly follows caesarean section and subsequent post-operative wound infection. Only a handful of cases have been published in the literature.
Abhilash Nali +3 more
doaj +2 more sources
Successful pregnancy and delivery following surgical treatment of postmyomectomy uterocutaneous fistula [PDF]
BMJ Case Reports, 2019 Uterocutaneous fistula is an extremely rare clinical condition that may be caused by postoperative or postpartum complications, such as infection or inflammation. Although fibroids and myomectomy are common clinical entities among women of reproductive age, there are very few postmyomectomy uterocutaneous fistula cases in the literature.
Mert Yesiladalı +2 more
exaly +6 more sources
Uterocutaneous Fistula Complicating Caesarean Section: A Case Report
Annals of Health Research, 2023 A uterocutaneous fistula (UCF) is a rare clinical presentation following Caesarean section (CS) and other pelvic surgeries. Presently, there are limited reports on the clinical management of UCF.
Akiseku AK, Popoola MA, Olatunji AO
doaj +3 more sources
Utero-cutaneous Fistula after Multiple Abdominal Myomectomies: A Case Report [PDF]
Balkan Medical Journal, 2015 Background: Utero-cutaneous fistula (UCF) is an extremely rare entity and only a few case reports have been published. Most UCFs develop secondary to postpartum or postoperative complications.
Mehmet Özgür Akkurt +4 more
doaj +2 more sources
Case Rep Obstet Gynecol, 2015 Introduction. Tubocutaneous fistula is a very rare condition; most cases described in the literature are secondary to endometriosis, tuberculosis, and complications of child birth and gynecological operations. Case Presentation. We report a case of 40‐year‐old woman who presented with tubocutaneous fistula secondary to pelvic inflammatory disease which
Nayini K, Gie C.
europepmc +2 more sources